Brief: Vicore Pharma Changes Listing To Nasdaq Stockholm's Main Market
Sept 11 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* VICORE PHARMA HAS BEEN APPROVED FOR LISTING ON NASDAQ
STOCKHOLM
* FIRST DAY OF TRADING ON NASDAQ STOCKHOLM IS EXPECTED TO BE
FRIDAY SEPTEMBER 27, 2019
* LAST DAY OF TRADING ON NASDAQ FIRST NORTH GROWTH MARKET IS
EXPECTED TO BE THURSDAY SEPTEMBER 26, 2019
Source text for Eikon: ID:nWkrbR593p
Further company coverage: VICOR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2